Lacosamide Tablet, Film Coated
Product Images NDC 70518-4505

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70518-4505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This text provides information about Lacosamide Tablets with a dosage of 100 mg and a quantity of 30 tablets. The tablets are oval and yellow with the imprint "L424". The medication is repackaged by RemedyRepack Inc. and the original manufacturer is Alembic Pharma. Storage instructions recommend keeping the medication at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). It is important to keep this medication out of reach of children. Furthermore, the text includes details such as NDC numbers, expiration date, and a reminder to see the insert for usual dosage instructions.*
FDA Label Image

Figure1 (Lacosamide Figure 1)

FDA Label Image

Figure2 (Lacosamide Figure 2)

Figure2 (Lacosamide Figure 2)
This is data showing the responder rate for Lacosamide and placebo groups in studies 2, 3, and 4. It includes the proportion of patients with improvements and worsening outcomes at different dosage levels of Lacosamide compared to placebo.*
FDA Label Image

Figure 3 (Lacosamide Figure3)

FDA Label Image

Structure (Lacosamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.